%0 Journal Article
%T Assessment of the Quality of Life of Patients with Mycobacterial Pulmonary Diseases
%A Khadidia Ouattara
%A Bocar Baya
%A Dianguina Soumar¨¦
%A Tenin Kanout¨¦
%A Mohamed Tolofodie
%A Kafui Komla Gaglo Koudemon
%A Salif Kon¨¦
%A Bassirou Diarra
%A Yaya Sadio Sarro
%A Yacouba Toloba
%A Mamoudou Maiga
%J Open Journal of Respiratory Diseases
%P 56-63
%@ 2163-9418
%D 2022
%I Scientific Research Publishing
%R 10.4236/ojrd.2022.122005
%X <b><span style=\"font-family:Verdana;\">Introduction: </span></b><span style=\"font-family:;\" \"=\"\"><span style=\"font-family:Verdana;\">Mycobacteria pulmonary diseases are chronic illnesses with various
impacts on patients¡¯ health status, and wellbeing. These diseases currently
represent a global health issue due to increasing burdens and the lack of new
development on therapeutic options. Policies based on the quality of life may
help to improve the management of this chronic respiratory disease; this study
was designed to assess the quality of life of patients treated for the
pulmonary mycobacterial disease.</span><b><span style=\"font-family:Verdana;\"> Materials and Methods: </span></b><span style=\"font-family:Verdana;\">Participants
diag</span><span style=\"font-family:Verdana;\">nosed with a mycobacterial pulmonary
disease were selected from the</span><span style=\"font-family:Verdana;\"> University Clinical Research Centers¡¯
(UCRC) 2019 mycobacterial cohort database. A telephone interview was conducted
using the Medical Outcome Study Short Form (SF-36) which has 36 items
evaluating physical and mental wellb</span><span style=\"font-family:Verdana;\">eing.
Scores range from 0</span></span><span style=\"font-family:Verdana;\"> - </span><span style=\"font-family:Verdana;\">100, with higher scores indicating greate</span><span style=\"font-family:Verdana;\">r Health-</span><span style=\"font-family:;\" \"=\"\"><span style=\"font-family:Verdana;\">related
quality of life (HRQOL). Statistical analysis was performed with SPSS 23.0 and
the Fisher test was used to compare percentages. A p-value less than 0</span><span><span style=\"font-family:Verdana;\">.05 was considered significant.</span><b><span style=\"font-family:Verdana;\"> Results: </span></b><span style=\"font-family:Verdana;\">A
total of 26 participants were</span></span><span style=\"font-family:Verdana;\"> reached and interviewed by phone. The mean
age was 42</span></span><span style=\"font-family:;\" \"=\"\"> </span><span style=\"font-family:Verdana;\">¡À</span><span style=\"font-family:;\" \"=\"\"> </span><span style=\"font-family:;\" \"=\"\"><span style=\"font-family:Verdana;\">10.6 years, and 76.9%
(20/26) were male. The most common cause of the mycobacterial pulmonary disease
was </span><i><span style=\"font-family:Verdana;\">Mycobacterium tuberculosis</span></i><span style=\"font-family:Verdana;\">,
with 84.6% (22/26). Four cases of Non-Tuberculous Mycobacteria (NTM) were diagnosed
including one </span><i><span style=\"font-family:Verdana;\">Mycobacterium avium
%K Quality of Life
%K Mycobacteria
%K Lung
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=117194